Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFRODITE study of dronedarone add-on versus intensified rate control in atrial fibrillation
NL-OMON36263Phase 4Active, not recruiting
- Sponsor
- Sanofi
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dronedarone in Atrial fibrillation (AFib) (2 arms), sponsored by Sanofi. Primary endpoint: Ventricular rate after 1 week. Started Apr 2010; status: active, not recruiting.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON36263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36263.